LeonaBio (LONA)
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-res...
- Open
- 7.950
- High
- 8.110
- Low
- 7.570
- Prev. Close
- 7.830
- Volume
- 8.95K
- Turnover
- 69.43K
- Avg Price
- 7.754
- Bid/Ask Ratio
- 98.02%
- Amplitude
- 6.90%
- 52wk High
- 14.210
- Volume Ratio
- 0.96
- Turnover Ratio
- 0.14%
LeonaBio Analyst Rating
View moreForecast & Rating
Aug 18, 2026Price forecast
$17.33125.11%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 1 day ago, 01:12 PM
Mizuho Cuts Athira Pharma (NASDAQ:LONA) Price Target to $15.00
- Market Beat · Aug 17 at 08:12 AM
Athira Pharma (NASDAQ:LONA) Price Target Lowered to $17.00 at Citizens Jmp
- Earnings Watch · Aug 15 at 12:23 AM
LeonaBio | 8-K: FY2026 Q2 Revenue: USD 0
- Market Beat · Aug 14 at 06:11 PM
Athira Pharma (NASDAQ:LONA) Announces Quarterly Earnings Results
- PUBT · Aug 12 at 06:15 AM
LeonaBio targets Phase 3 ELAINE-3 enrollment completion in Q4 2026, topline data seen in H2 2027
- PUBT · Aug 12 at 06:05 AM
LeonaBio spotlights lasofoxifene at DAVA Oncology breast cancer summit
